1. Home
  2. ZKH vs RAPP Comparison

ZKH vs RAPP Comparison

Compare ZKH & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZKH
  • RAPP
  • Stock Information
  • Founded
  • ZKH 1998
  • RAPP 2022
  • Country
  • ZKH China
  • RAPP United States
  • Employees
  • ZKH N/A
  • RAPP N/A
  • Industry
  • ZKH
  • RAPP
  • Sector
  • ZKH
  • RAPP
  • Exchange
  • ZKH Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • ZKH 462.2M
  • RAPP 439.4M
  • IPO Year
  • ZKH 2023
  • RAPP 2024
  • Fundamental
  • Price
  • ZKH $2.85
  • RAPP $28.03
  • Analyst Decision
  • ZKH Buy
  • RAPP Strong Buy
  • Analyst Count
  • ZKH 1
  • RAPP 3
  • Target Price
  • ZKH $4.00
  • RAPP $34.67
  • AVG Volume (30 Days)
  • ZKH 33.6K
  • RAPP 977.4K
  • Earning Date
  • ZKH 08-22-2025
  • RAPP 11-06-2025
  • Dividend Yield
  • ZKH N/A
  • RAPP N/A
  • EPS Growth
  • ZKH N/A
  • RAPP N/A
  • EPS
  • ZKH N/A
  • RAPP N/A
  • Revenue
  • ZKH $1,221,845,808.00
  • RAPP N/A
  • Revenue This Year
  • ZKH $9.96
  • RAPP N/A
  • Revenue Next Year
  • ZKH $10.56
  • RAPP N/A
  • P/E Ratio
  • ZKH N/A
  • RAPP N/A
  • Revenue Growth
  • ZKH N/A
  • RAPP N/A
  • 52 Week Low
  • ZKH $2.50
  • RAPP $6.43
  • 52 Week High
  • ZKH $4.07
  • RAPP $42.27
  • Technical
  • Relative Strength Index (RSI)
  • ZKH 38.82
  • RAPP 71.02
  • Support Level
  • ZKH $2.82
  • RAPP $14.11
  • Resistance Level
  • ZKH $2.96
  • RAPP $42.27
  • Average True Range (ATR)
  • ZKH 0.12
  • RAPP 2.87
  • MACD
  • ZKH -0.00
  • RAPP 1.31
  • Stochastic Oscillator
  • ZKH 33.33
  • RAPP 49.81

About ZKH ZKH Group Limited each representing thirty-five (35)

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: